Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Hannelius

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes, Obesity & Metabolism|April 18, 2022
Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetesChristoph Nowak, Ulf Hannelius, Johnny Ludvigsson
Diabetologia|August 6, 2020
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetesUlf Hannelius, Craig A Beam, Johnny Ludvigsson
BMC Cancer|March 2, 2012
The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancerGustaf Rosin, Ulf Hannelius, Linda Lindström, et al.
BMC Genetics|August 21, 2008
Population substructure in Finland and Sweden revealed by the use of spatial coordinates and a small number of unlinked autosomal SNPsUlf Hannelius, Elina Salmela, Tuuli Lappalainen, et al.
BMJ Open|October 31, 2022
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocolJohnny Ludvigsson, Linnea Eriksson, Christoph Nowak, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|August 22, 2007
Large-scale zygosity testing using single nucleotide polymorphismsUlf Hannelius, Loreana Gherman, Ville-Veikko Mäkelä, et al.
Annals of Medicine|August 30, 2006
G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndromeVille Pulkkinen, Ritva Haataja, Ulf Hannelius, et al.
Diabetologia|February 14, 2024
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available dataPedro F Teixeira, Tadej Battelino, Anneli Carlsson, et al.
Breast Cancer Research and Treatment|February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variantOfure Obazee, Christina Justenhoven, Stefan Winter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2022
Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2Christoph Nowak, Marcus Lind, Zdenek Sumnik, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|April 18, 2022
Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetesChristoph Nowak, Ulf Hannelius, Johnny Ludvigsson
Diabetologia|August 6, 2020
Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetesUlf Hannelius, Craig A Beam, Johnny Ludvigsson
BMC Cancer|March 2, 2012
The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancerGustaf Rosin, Ulf Hannelius, Linda Lindström, et al.
BMC Genetics|August 21, 2008
Population substructure in Finland and Sweden revealed by the use of spatial coordinates and a small number of unlinked autosomal SNPsUlf Hannelius, Elina Salmela, Tuuli Lappalainen, et al.
BMJ Open|October 31, 2022
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocolJohnny Ludvigsson, Linnea Eriksson, Christoph Nowak, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|August 22, 2007
Large-scale zygosity testing using single nucleotide polymorphismsUlf Hannelius, Loreana Gherman, Ville-Veikko Mäkelä, et al.
Annals of Medicine|August 30, 2006
G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndromeVille Pulkkinen, Ritva Haataja, Ulf Hannelius, et al.
Diabetologia|February 14, 2024
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available dataPedro F Teixeira, Tadej Battelino, Anneli Carlsson, et al.
Breast Cancer Research and Treatment|February 23, 2013
Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variantOfure Obazee, Christina Justenhoven, Stefan Winter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2022
Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2Christoph Nowak, Marcus Lind, Zdenek Sumnik, et al.
Pageof 2